BRIEF published on 07/16/2024 at 08:05, 1 year 4 months ago AMA Announces XpertEye Compatibility with Mistral Innovation AI Productivity XpertEye Compatibility
REGULATED PRESS RELEASE published on 07/16/2024 at 08:00, 1 year 4 months ago AMA announces XpertEye compatibility with Mistral AMA announces XpertEye compatibility with Mistral, enhancing AI capabilities for frontline workers. Integration offers versatile solutions for customers seeking innovative tools AI Frontline Workers XpertEye AMA Mistral
BRIEF published on 05/29/2024 at 19:35, 1 year 6 months ago AMA: New Strategic Direction to Accelerate Innovation and Boost Growth Innovation AI Strategic Plan Cost Reduction Leadership
REGULATED PRESS RELEASE published on 05/29/2024 at 19:30, 1 year 6 months ago AMA: New strategic direction to accelerate innovation and boost growth AMA Corporation PLC announces strategic action plan to accelerate innovation and growth through AI implementation, renewed governance and streamlined leadership AMA CORPORATION PLC AI Implementation Strategic Action Plan Accelerate Innovation Renewed Governance
BRIEF published on 04/25/2024 at 18:05, 1 year 7 months ago AMA Corporation Reports Revenue Decline but Strong Recovery Efforts in 2023 Artificial Intelligence Revenue Decline AMA Corporation 2023 Financial Performance Strategic Innovations
REGULATED PRESS RELEASE published on 04/25/2024 at 18:00, 1 year 7 months ago AMA: 2023 full-year earnings and 2024 first-quarter revenues AMA Corporation announces significant reduction in losses for 2023 and reveals innovations to drive growth in 2024, with focus on financial performance and strategic positioning Revenues Financial Performance Innovations Earnings AMA Corporation
BRIEF published on 03/07/2024 at 08:05, 1 year 8 months ago Sopra Steria and AMA Amplify Their Strategic Partnership in AI-Driven Data Management Artificial Intelligence Data Management Technological Innovation Sopra Steria AMA Corporation
REGULATED PRESS RELEASE published on 03/07/2024 at 08:00, 1 year 8 months ago Sopra Steria and AMA Reinforce Strategic Partnership to Pioneer in AI-Driven Data Management Sopra Steria and AMA reinforce strategic partnership to pioneer in AI-driven data management, leveraging XpertEye application data seamlessly into advanced AI solutions Partnership XpertEye Sopra Steria AMA AI-driven Data Management
REGULATED PRESS RELEASE published on 01/31/2024 at 08:00, 1 year 10 months ago AMA: FY 2023 Revenues AMA Corporation PLC (ALAMA) reports FY 2023 revenues of €3 million (-28%) and 55% growth in Q4 2023 orders, focuses on interoperability and AI, targets wider solution adoption in 2024. Financial calendar and contact information included Revenues Artificial Intelligence Interoperability Financial Calendar AMA CORPORATION PLC
REGULATED PRESS RELEASE published on 12/13/2023 at 08:00, 1 year 11 months ago AMA Introduces AI-powered Intelligent Report for Enhanced Productivity
Published on 12/05/2025 at 02:35, 4 hours 42 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 17 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 12 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 17 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 17 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 2 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 17 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 32 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 33 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
